Chimerix shares crater after late-stage trial fails

Phase 3 trial of a drug used to prevent infections did not meet its goal.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.